They have always publicly stated that they are open to all outcomes but real value materialises after a successful P3 Trial.
If they are "extremely happy" with the quality and quantity of pharma interest in 2591 and you think it will be "game on" once the endpoints are sorted, the interest must really positive, given their stated position.
NEU Price at posting:
$9.31 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)